{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:50:43Z","timestamp":1748929843419},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,5]]},"DOI":"10.1093\/infdis\/jiab517","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T04:28:06Z","timestamp":1633148886000},"page":"1-4","source":"Crossref","is-referenced-by-count":11,"title":["Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in Blood Donor Populations"],"prefix":"10.1093","volume":"225","author":[{"given":"Eshan U","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan M","family":"Bloch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron A R","family":"Tobian","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"2022010518595933700_CIT0001","doi-asserted-by":"crossref","first-page":"e0252617","DOI":"10.1371\/journal.pone.0252617","article-title":"Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis.","volume":"16","author":"Bobrovitz","year":"2021","journal-title":"PLoS One"},{"key":"2022010518595933700_CIT0002","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/516534","article-title":"Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas\u2019 disease, in US blood donors.","volume":"176","author":"Leiby","year":"1997","journal-title":"J Infect Dis"},{"key":"2022010518595933700_CIT0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa044333","article-title":"West Nile virus among blood donors in the United States, 2003 and 2004.","volume":"353","author":"Stramer","year":"2005","journal-title":"N Engl J Med"},{"key":"2022010518595933700_CIT0004","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2020.18598","article-title":"Change in donor characteristics and antibodies to SARS-CoV-2 in donated blood in the US, June-August 2020.","volume":"324","author":"Dodd","year":"2020","journal-title":"JAMA"},{"key":"2022010518595933700_CIT0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2021.07.001","article-title":"Characteristics of US blood donors testing reactive for antibodies to SARS-CoV-2 prior to the availability of authorized vaccines.","volume":"35","author":"Dodd","year":"2021","journal-title":"Transfus Med Rev"},{"key":"2022010518595933700_CIT0006","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021.","volume":"326","author":"Jones","year":"2021","journal-title":"JAMA"},{"key":"2022010518595933700_CIT0007","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab537","article-title":"Use of US blood donors for national serosurveillance of severe acute respiratory syndrome coronavirus 2 antibodies: basis for an expanded national donor serosurveillance program.","author":"Stone","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022010518595933700_CIT0008","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jama.2021.15265","article-title":"Prevalence of SARS-CoV-2 antibodies from a national serosurveillance of Kenyan blood donors, January-March 2021.","volume":"326","author":"Uyoga","year":"2021","journal-title":"JAMA"},{"key":"2022010518595933700_CIT0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/infdis\/jiab514","article-title":"Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: impact of vaccination, United States December 2020 \u2013 June 2021.","volume":"225","author":"Dodd","year":"2022","journal-title":"J Infect Dis"},{"key":"2022010518595933700_CIT0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2009.09.005","article-title":"Motivators and barriers to blood donation in African American college students.","volume":"41","author":"Shaz","year":"2009","journal-title":"Transfus Apher Sci"},{"key":"2022010518595933700_CIT0011","doi-asserted-by":"crossref","first-page":"814842","DOI":"10.1155\/2013\/814842","article-title":"Cancer incidence and mortality in a cohort of US blood donors: a 20-year study.","volume":"2013","author":"Vahidnia","year":"2013","journal-title":"J Cancer Epidemiol"},{"key":"2022010518595933700_CIT0012","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/trf.15179","article-title":"Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study.","volume":"59","author":"Patel","year":"2019","journal-title":"Transfusion"},{"key":"2022010518595933700_CIT0013","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1111\/trf.15415","article-title":"Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study.","volume":"59","author":"Patel","year":"2019","journal-title":"Transfusion"},{"key":"2022010518595933700_CIT0014","doi-asserted-by":"crossref","first-page":"818","DOI":"10.15585\/mmwr.mm7022e1","article-title":"Patterns in COVID-19 vaccination coverage, by social vulnerability and urbanicity\u2014United States, December 14, 2020-May 1, 2021.","volume":"70","author":"Barry","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022010518595933700_CIT0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.15585\/mmwr.mm7025e1","article-title":"COVID-19 vaccination coverage among adults\u2014United States, December 14, 2020-May 22, 2021.","volume":"70","author":"Diesel","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022010518595933700_CIT0016","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.15585\/mmwr.mm7032a2","article-title":"Alternative methods for grouping race and ethnicity to monitor COVID-19 outcomes and vaccination coverage.","volume":"70","author":"Yoon","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022010518595933700_CIT0017","doi-asserted-by":"crossref","first-page":"e2036462","DOI":"10.1001\/jamanetworkopen.2020.36462","article-title":"Association of social and demographic factors with COVID-19 incidence and death rates in the US.","volume":"4","author":"Karmakar","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2022010518595933700_CIT0018","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1537-2995.2011.03270.x","article-title":"The healthy donor effect: a matter of selection bias and confounding.","volume":"51","author":"Atsma","year":"2011","journal-title":"Transfusion"},{"key":"2022010518595933700_CIT0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.15585\/mmwr.mm7015e2","article-title":"Trends in racial and ethnic disparities in COVID-19 hospitalizations, by region\u2014United States, March-December 2020.","volume":"70","author":"Romano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022010518595933700_CIT0020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.15585\/mmwr.mm7033a2","article-title":"Disparities in excess mortality associated with COVID-19 - United States, 2020.","volume":"70","author":"Rossen","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022010518595933700_CIT0021","doi-asserted-by":"crossref","first-page":"985","DOI":"10.15585\/mmwr.mm7028a1","article-title":"COVID-19 vaccination coverage among insured persons aged \u226516 years, by race\/ethnicity and other selected characteristics\u2014eight integrated health care organizations, United States, December 14, 2020-May 15, 2021.","volume":"70","author":"Pingali","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022010518595933700_CIT0022","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3201\/eid2609.201840","article-title":"Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity.","volume":"26","author":"Clapham","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2022010518595933700_CIT0023","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1172\/JCI142004","article-title":"Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.","volume":"130","author":"Klein","year":"2020","journal-title":"J Clin Invest"},{"key":"2022010518595933700_CIT0024","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/infdis\/jiaa581","article-title":"SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors.","volume":"222","author":"Benner","year":"2020","journal-title":"J Infect Dis"},{"key":"2022010518595933700_CIT0025","doi-asserted-by":"crossref","first-page":"e02257","DOI":"10.1128\/JCM.02257-20","article-title":"Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers.","volume":"59","author":"Patel","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2022010518595933700_CIT0026","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/trf.16555","article-title":"SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: dependency on assay format and applicability to serosurveillance.","volume":"61","author":"Di Germanio","year":"2021","journal-title":"Transfusion"},{"key":"2022010518595933700_CIT0027","article-title":"Evaluation of commercially available high-throughput SARS-CoV-2 serological assays for serosurveillance and related applications.","author":"Stone","journal-title":"medRxiv"},{"key":"2022010518595933700_CIT0028","doi-asserted-by":"crossref","first-page":"eabh3409","DOI":"10.1126\/sciadv.abh3409","article-title":"SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.","volume":"7","author":"Peluso","year":"2021","journal-title":"Sci Adv"},{"key":"2022010518595933700_CIT0029","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/infdis\/jiaa523","article-title":"Are seroprevalence estimates for severe acute respiratory syndrome coronavirus 2 biased?","volume":"222","author":"Takahashi","year":"2020","journal-title":"J Infect Dis"},{"key":"2022010518595933700_CIT0030","article-title":"SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency.","author":"Takahashi","journal-title":"medRxiv"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab517\/40539539\/jiab517.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/1\/1\/41937234\/jiab517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/1\/1\/41937234\/jiab517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:09:33Z","timestamp":1673395773000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/1\/1\/6385560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,10,9]]},"published-print":{"date-parts":[[2022,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab517","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,10,9]]}}}